BioCentury | Dec 19, 2018
Distillery Therapeutics

Hematology

...bleeding. Bayer AG and Nordic Group market Trasylol for bleeding. Ferring Pharmaceuticals A/S market Lysteda tranexamic acid...
BioCentury | Sep 19, 2016
Clinical News

LB1148: Phase II started

...Calif. Product: LB1148 Business: Gastrointestinal Molecular target: Serine protease Description: Broad-spectrum serine protease inhibitor comprising tranexamic acid...
BioCentury | Nov 12, 2015
Distillery Therapeutics

Therapeutics: Thrombin (Factor IIa; F2)

...loaded with thrombin could help stop bleeding. The porous particles consisted of calcium carbonate and tranexamic acid...
BioCentury | Nov 12, 2015
Translation in Brief

Going up

...simplest version of the system consists of only calcium carbonate and a protonated version of tranexamic acid...
...liver puncture, topical application of propelled particles carrying thrombin decreased blood loss compared with non-propelled tranexamic acid...
BioCentury | Sep 28, 2015
Emerging Company Profile

Microparticle man

...mortality, and is available in the U.S. for investigational use only. NovoSeven eptacog alfa and tranexamic acid...
BioCentury | Jul 27, 2015
Clinical News

NPH29: Clinical trial data

...and instrumentally measured L*a*b*L values from baseline to day 30 vs. both vehicle cream and tranexamic acid...
BioCentury | Sep 16, 2013
Company News

Buderer Drug, Imprimis deal

...Imprimis acquired IP for wound healing product IPI-120, a transdermal formulation of tranexamic acid and an antibiotic...
BioCentury | Oct 22, 2012
Clinical News

Cyklokapron tranexamic acid regulatory update

...evidence summary stating that a large international study showed that off-label use of Pfizer's Cyklokapron tranexamic acid...
...there are no clinically appropriate licensed alternatives. Pfizer Inc. (NYSE:PFE), New York, N.Y. Product: Cyklokapron tranexamic acid...
BioCentury | Oct 8, 2012
Clinical News

MDCO-2010: Development discontinued

...later date. The double-blind, placebo-controlled, German and Swiss Phase IIb trial was comparing MDCO-2010 to tranexamic acid...
BioCentury | Oct 6, 2012
Clinical News

Medicines Co. discontinues MDCO-2010

...later date. The double-blind, placebo-controlled, German and Swiss Phase IIb trial was comparing MDCO-2010 to tranexamic acid...
Items per page:
1 - 10 of 48